Contrast-Enhanced Ultrasound in the Follow-Up of Choroidal Melanoma Patients: Features of Liver Metastasis Arising Several Years after Treatment of the Primary Tumor

by Enrico N. De Toni, Eike Gallmeier, Christoph J. Auernhammer, Dirk-André Clevert
Published 2011-07-01

Inactivation of PRIM1 Function Sensitizes Cancer Cells to ATR and CHK1 Inhibitors

by Albert Job, Lisa-Maria Schmitt, Lisa von Wenserski, Brigitte Lankat-Buttgereit, Thomas M. Gress, Malte Buchholz, Eike Gallmeier
Published 2018-11-01

Loss of TRAIL-receptors is a recurrent feature in pancreatic cancer and determines the prognosis of patients with no nodal metastasis after surgery.

by Eike Gallmeier, Dominik C Bader, Lydia Kriegl, Sabina Berezowska, Hendrik Seeliger, Burkhard Göke, Thomas Kirchner, Christiane Bruns, Enrico N De Toni
Published 2013-01-01

Microsatellite instability, KRAS mutations and cellular distribution of TRAIL-receptors in early stage colorectal cancer.

by Lydia Kriegl, Andreas Jung, David Horst, Antonia Rizzani, Rene Jackstadt, Heiko Hermeking, Eike Gallmeier, Alexander L Gerbes, Thomas Kirchner, Burkhard Göke, Enrico N De Toni
Published 2012-01-01

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled...

by Thomas J. Ettrich, Andreas W. Berger, Lukas Perkhofer, Severin Daum, Alexander König, Andreas Dickhut, Uwe Wittel, Kai Wille, Michael Geissler, Hana Algül, Eike Gallmeier, Jens Atzpodien, Marko Kornmann, Rainer Muche, Nicole Prasnikar, Andrea Tannapfel, Anke Reinacher-Schick, Waldemar Uhl, Thomas Seufferlein
Published 2018-12-01